{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:11:47Z","timestamp":1787897507919,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018270","name":"Health Service Executive","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.061","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T06:24:32Z","timestamp":1709187872000},"page":"2099-2105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011\u20132021"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-9966","authenticated-orcid":false,"given":"Sarah","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-777X","authenticated-orcid":false,"given":"Catherine","family":"Comiskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.061_bib171","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.061_b0005","unstructured":"HSE Health Protection Surveillance Centre. Immunisation uptake at 12 and 24 months of age, 2014 2015. https:\/\/www.hpsc.ie\/a-z\/vaccinepreventable\/vaccination\/immunisationuptakestatistics\/immunisationuptakestatisticsat12and24monthsofage\/annualreports\/File,15395,en.pdf (accessed January 21, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0010","unstructured":"Health Information & Quality Authority. Health technology assessment of a selective BCG vaccination programme 2015. https:\/\/www.hiqa.ie\/reports-and-publications\/health-technology-assessment\/hta-bcg-vaccination-programme (accessed January 21, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0015","unstructured":"HSE Health Protection Surveillance Centre. Tuberculosis in Ireland: provisional trends in surveillance data. 2023. https:\/\/www.hpsc.ie\/a-z\/vaccinepreventable\/tuberculosistb\/tbdataandreports\/TB%20Trends%20in%20Ireland%202018-2022.pdf (accessed January 21, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0020","unstructured":"The BCG World Atlas, 3rd Edition 2023. http:\/\/www.bcgatlas.org\/index.php (accessed January 19, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0025","unstructured":"National Immunisation Advisory Committee. Selective strategy for BCG vaccination 2022. https:\/\/rcpi.access.preservica.com\/uncategorized\/IO_8c572e88-025e-4b90-8e87-bc11e40f6f16\/ (accessed February 12, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/INF.0000000000001891","article-title":"Economic evaluation of selective neonatal bacillus calmette-gu\u00e9rin vaccination of high-risk infants in Ireland","volume":"37","author":"Teljeur","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.02.061_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13690-016-0141-0","article-title":"Evaluating the neonatal BCG vaccination programme in Ireland","volume":"74","author":"Usher","year":"2016","journal-title":"Archives of Public Health"},{"key":"10.1016\/j.vaccine.2024.02.061_b0040","unstructured":"HSE Health Protection Surveillance Centre. Tuberculosis epidemiological reports \u2013 technical notes. Technical Notes 2023. https:\/\/www.hpsc.ie\/a-z\/vaccinepreventable\/tuberculosistb\/tbdataandreports\/TB%20report%20technical%20notes%2020230322%20v2.0.pdf (accessed January 3, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0045","unstructured":"European Commission. EU Tuberculosis case definitions. Commission Implementing Decision (EU) 2018\/945. Official Journal of the European Union 2018. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32018D0945&from=EN#page=47 (accessed January 19, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0050","unstructured":"Central Statistics Office. Population usually resident and present in the State 2011 to 2016; by birthplace and single year of age 2016. https:\/\/data.cso.ie\/ (accessed January 15, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0055","unstructured":"Central Statistics Office. Population usually resident and present in the state 2011 to 2016; by single year of age and Local Health Area. (Accessed via Health Atlas Ireland) 2016."},{"key":"10.1016\/j.vaccine.2024.02.061_b0060","series-title":"Stata statistical software: release 14","author":"StataCorp","year":"2015"},{"key":"10.1016\/j.vaccine.2024.02.061_b0065","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R version 4.3.1 2023."},{"key":"10.1016\/j.vaccine.2024.02.061_b0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2024.02.061_b0075","unstructured":"Infectious Diseases Regulations, S.I. No. 390. Ireland: 1981."},{"key":"10.1016\/j.vaccine.2024.02.061_b0080","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.12.19824-en","article-title":"Assessing BCG vaccination coverage and incidence of paediatric tuberculosis following two major changes in BCG vaccination policy in France","volume":"16","author":"Guthmann","year":"2011","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2024.02.061_b0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0398-7620(05)84727-3","article-title":"Estimation de l\u2019impact \u00e9pid\u00e9miologique de diff\u00e9rentes options de vaccination BCG en France","volume":"53","author":"L\u00e9vy-Bruhl","year":"2005","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.vaccine.2024.02.061_b0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0041-3879(83)90034-X","article-title":"Childhood tuberculosis in Sweden. an epidemiological study made six years after the cessation of general BCG vaccination of the newborn","volume":"64","author":"Romanus","year":"1983","journal-title":"Tubercle"},{"key":"10.1016\/j.vaccine.2024.02.061_b0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0962-8479(92)90149-E","article-title":"The impact of changing BCG coverage on tuberculosis incidence in swedish-born children between 1969 and 1989","volume":"73","author":"Romanus","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.vaccine.2024.02.061_b0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0962-8479(93)90006-J","article-title":"Six years\u2019 experience with the discontinuation of BCG vaccination","volume":"74","author":"Trnka","year":"1993","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.vaccine.2024.02.061_b0105","first-page":"24","article-title":"Brooks-Pollock E. Estimating the effect of the change in BCG policy in England: a retrospective cohort study, 2000 to 2015","volume":"2019","author":"Abbott","year":"2005","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2024.02.061_b0110","doi-asserted-by":"crossref","unstructured":"Kontturi A, Kekom\u00e4ki S, Soini H, Ollgren J, Salo E. Paediatric tuberculosis during universal and selective Bacillus Calmette\u2013Gu\u00e9rin vaccination policy: a nationwide population-based retrospective study, Finland, 1995\u20132015. Eurosurveillance 2021;26. 10.2807\/1560-7917.ES.2021.26.11.1900711.","DOI":"10.2807\/1560-7917.ES.2021.26.11.1900711"},{"key":"10.1016\/j.vaccine.2024.02.061_b0115","doi-asserted-by":"crossref","unstructured":"Van Bui T, L\u00e9vy-Bruhl D, Che D, Antoine D, Jarlier V, Robert J. Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011. Eurosurveillance 2015;20. 10.2807\/1560-7917.ES2015.20.11.21064.","DOI":"10.2807\/1560-7917.ES2015.20.11.21064"},{"key":"10.1016\/j.vaccine.2024.02.061_b0120","first-page":"2018","article-title":"Norwegian Institute of Public Health","volume":"1","author":"N\u00f8kleby","year":"2018","journal-title":"Evaluation and revision of advice on BCG vaccination effective from"},{"key":"10.1016\/j.vaccine.2024.02.061_b0125","series-title":"CIDR","author":"HSE Health Protection Surveillance Centre","year":"2023"},{"key":"10.1016\/j.vaccine.2024.02.061_b0130","unstructured":"World Health Organization. WHO global lists of high burden countries for tuberculosis (TB), TB\/HIV and multidrug\/rifampicin-resistant TB (MDR\/RR-TB), 2021\u20132025 2021. https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-tuberculosis\/who_globalhbcliststb_2021-2025_backgrounddocument.pdf?sfvrsn=f6b854c2_9 (accessed February 13, 2024)."},{"key":"10.1016\/j.vaccine.2024.02.061_b0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1590\/s1806-37562017000000461","article-title":"Epidemiological aspects, clinical manifestations, and prevention of pediatric tuberculosis from the perspective of the end TB strategy","volume":"44","author":"Carvalho","year":"2018","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.vaccine.2024.02.061_b0140","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2024.02.061_b0145","doi-asserted-by":"crossref","first-page":"1701414","DOI":"10.1183\/13993003.01414-2017","article-title":"Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker","volume":"50","author":"Luzzati","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2024.02.061_b0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2334-14-295","article-title":"The epidemiology of childhood tuberculosis in the Netherlands: still room for prevention","volume":"14","author":"Erkens","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.061_b0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12879-019-4026-z","article-title":"Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland","volume":"19","author":"Sweeney","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.061_b0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1008049","article-title":"Tuberculosis in children","volume":"367","author":"Perez-Velez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.02.061_b0165","doi-asserted-by":"crossref","first-page":"e0001018","DOI":"10.1371\/journal.pgph.0001018","article-title":"Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV\/AIDS and malaria\u2013a systematic review","volume":"3","author":"Kessel","year":"2023","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.vaccine.2024.02.061_b0170","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0264-2021","article-title":"COVID-19 and tuberculosis: the double whammy of respiratory pathogens","volume":"31","author":"Shariq","year":"2022","journal-title":"Eur Respir Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:54:44Z","timestamp":1714992884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24002202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24002202"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011\u20132021","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}